Table 2 Antimicrobial susceptibility of 36 rmpA-positive K. pneumoniae isolates from patients with bloodstream infections.
Antimicrobial agent | Susceptible | Intermediate | Resistant |
|---|---|---|---|
Ampicillin | 1 (2.8) | 8 (22.2) | 27 (75.0) |
Ampicillin/sulbactam | 33 (91.7) | 1 (2.8) | 2 (5.6) |
Piperacillin | 32 (88.9) | 1 (2.8)a | 3 (8.3) |
Piperacillin/tazobactam | 35 (97.2) | 0 (0.0)a | 1 (2.8) |
Cefmetazole | 36 (100.0) | 0 (0.0) | 0 (0.0) |
Cefotaxime | 34 (94.4) | 0 (0.0) | 2 (5.6) |
Ceftriaxone | 34 (94.4) | 0 (0.0) | 2 (5.6) |
Ceftazidime | 36 (100.0) | 0 (0.0) | 0 (0.0) |
Cefepime | 34 (94.4) | 1 (2.8)a | 1 (2.8) |
Ceftolozane/tazobactam | 35 (97.2) | 1 (2.8) | 0 (0.0) |
Imipenem | 33 (91.7) | 3 (8.3) | 0 (0.0) |
Meropenem | 36 (100.0) | 0 (0.0) | 0 (0.0) |
Aztreonam | 36 (100.0) | 0 (0.0) | 0 (0.0) |
Colistin | – | 36 (100.0) | 0 (0.0) |
Amikacin | 34 (94.4) | 2 (5.6) | 0 (0.0) |
Gentamicin | 35 (97.2) | 0 (0.0) | 1 (2.8) |
Ciprofloxacin | 33 (91.7) | 1 (2.8) | 2 (5.6) |
Levofloxacin | 33 (91.7) | 3 (8.3) | 0 (0.0) |
Minocycline | 35 (97.2) | 1 (2.8) | 0 (0.0) |
Sulfamethoxazole/trimethoprim | 33 (91.7) | 0 (0.0) | 3 (8.3) |
